Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) and Nephros (NASDAQ:NEPH – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, valuation, profitability, dividends, risk and analyst recommendations.
Profitability
This table compares Intelligent Bio Solutions and Nephros’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Intelligent Bio Solutions | -323.79% | -146.03% | -83.62% |
| Nephros | -6.86% | -11.39% | -8.30% |
Earnings and Valuation
This table compares Intelligent Bio Solutions and Nephros”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Intelligent Bio Solutions | $3.03 million | 2.90 | -$10.16 million | N/A | N/A |
| Nephros | $14.16 million | 1.50 | -$1.58 million | ($0.09) | -22.33 |
Institutional & Insider Ownership
33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 41.1% of Nephros shares are held by institutional investors. 0.3% of Intelligent Bio Solutions shares are held by insiders. Comparatively, 4.1% of Nephros shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Volatility & Risk
Intelligent Bio Solutions has a beta of 4.63, indicating that its share price is 363% more volatile than the S&P 500. Comparatively, Nephros has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Intelligent Bio Solutions and Nephros, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Intelligent Bio Solutions | 0 | 0 | 0 | 0 | 0.00 |
| Nephros | 0 | 0 | 1 | 0 | 3.00 |
Nephros has a consensus price target of $5.00, indicating a potential upside of 148.76%. Given Nephros’ stronger consensus rating and higher possible upside, analysts clearly believe Nephros is more favorable than Intelligent Bio Solutions.
Summary
Nephros beats Intelligent Bio Solutions on 10 of the 12 factors compared between the two stocks.
About Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
About Nephros
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Receive News & Ratings for Intelligent Bio Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Bio Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
